Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarkerWen Jiang, Guopei Zhu|BMC Medicine|2024Cited by 10
Postoperative Radiotherapy with Docetaxel Versus Cisplatin for High-Risk Oral Squamous Cell Carcinoma: A Randomized Phase II Trial with Exploratory Analysis of ITGB1 as a Potential Predictive BiomarkerWen Jiang, Shuyang Sun, Rongrong Li et al.|SSRN Electronic Journal|2023Cited by 1